The OECD Study on Private Health Insurance was completed between 2001 and 2004, and assessed the role that private health insurance (PHI) plays in OECD member countries. This page lists all reports released as part of the study.
Statistical work on biotechnology is carried out under the aegis of the OECD Working Party of National Experts on Science and Technology Indicators (NESTI). The above document gives the outcome of the 2004 experts' meeting.
What is the impact of private health insurance on health systems? This report provides the first-ever comparative analysis of the role
This volume contains a selection of the policy studies constituting the OECD Health Project.
Biological resources are the foundation of all biological sciences research. They provide the source material for scientific investigation, leading to many of the discoveries on which biotechnology is founded.
This document reflects recent efforts made by the OECD to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.
This volume offers a synthesis of findings from recent OECD studies undertaken as part of the three-year Health Project, an initiative geared towards answering many of the key questions facing today’s health policy makers.
This project was one component of the OECD Health Project . It sets out the main trends in long-term care expenditures and services and evaluates recent policy developments in 19 OECD countries.
English, , 260kb
This document provides a framework for the national certification (independent review by third party) of biological resource centres as defined by the OECD. Compliance with this guidance is mandatory for those bodies that are part of a Global Biological Resource Centre Network.
English, , 327kb
The OECD should strengthen its contribution to work on biotechnology as a driver for sustainable growth, focusing on the issues identified and conclusions reached in this paper.